mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.02 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
Tamoxifen |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |